Japan aims to fast-track review of anti-viral drug remdesivir
By Kiyoshi Takenaka
TOKYO (Reuters) - Japan will fast-track a review of Gilead Sciences Inc's antiviral drug remdesivir so that it can hopefully be approved for domestic COVID-19 patients a week after the U.S. firm's filing for such approval, the health minister said on Saturday.
……Read full article on Yahoo - World
Japan News International
One-stop lifestyle app dedicated to making life in Singapore a breeze!
English
简体中文
Comments
Leave a comment in Nestia App